<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell Dev. Biol.</journal-id>
<journal-title>Frontiers in Cell and Developmental Biology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell Dev. Biol.</abbrev-journal-title>
<issn pub-type="epub">2296-634X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">1610694</article-id>
<article-id pub-id-type="doi">10.3389/fcell.2025.1610694</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cell and Developmental Biology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Adult-onset hypothyroidism induces granulosa cell apoptosis and affects ovarian follicle development in rats</article-title>
<alt-title alt-title-type="left-running-head">Li et al.</alt-title>
<alt-title alt-title-type="right-running-head">
<ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fcell.2025.1610694">10.3389/fcell.2025.1610694</ext-link>
</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Li</surname>
<given-names>Shuyue</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2545555/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Zhang</surname>
<given-names>Lina</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>&#x2020;</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Li</surname>
<given-names>Wanqiong</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Qin</surname>
<given-names>Jiaying</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Qi</surname>
<given-names>Lingbin</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/887233/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Xiao</surname>
<given-names>Xi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Xue</surname>
<given-names>Zhigang</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1673270/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Xue</surname>
<given-names>Jinfeng</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/887601/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Ji</surname>
<given-names>Yazhong</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/Writing - review &#x26; editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Reproductive Medical Center</institution>, <institution>Department of Obstetrics and Gynecology</institution>, <institution>Tongji Hospital</institution>, <institution>Tongji University School of Medicine</institution>, <addr-line>Shanghai</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Stem Cell Research Center</institution>, <institution>School of Medicine</institution>, <institution>Tongji University</institution>, <addr-line>Shanghai</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Translational Center for Stem Cell Research</institution>, <institution>Tongji Hospital</institution>, <institution>Tongji University School of Medicine</institution>, <addr-line>Shanghai</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1926375/overview">Asok K. Dasmahapatra</ext-link>, University of Mississippi, United States</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2411993/overview">Gunes Taylor</ext-link>, The Francis Crick Institute, United Kingdom</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/3045057/overview">Sahar Mohamed</ext-link>, German University in Cairo, Egypt</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Zhigang Xue, <email>xuezg@tongji.edu.cn</email>; Jinfeng Xue, <email>xuejinfeng@me.com</email>; Yazhong Ji, <email>jiyazhong@tongji.edu.cn</email>
</corresp>
<fn fn-type="equal" id="fn001">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>30</day>
<month>05</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2025</year>
</pub-date>
<volume>13</volume>
<elocation-id>1610694</elocation-id>
<history>
<date date-type="received">
<day>12</day>
<month>04</month>
<year>2025</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>05</month>
<year>2025</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2025 Li, Zhang, Li, Qin, Qi, Xiao, Xue, Xue and Ji.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Li, Zhang, Li, Qin, Qi, Xiao, Xue, Xue and Ji</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<sec>
<title>Introduction</title>
<p>Hypothyroidism is a common endocrine disorder in women, which could lead to ovulation disorders and infertility, however, the effects of adult-onset hypothyroidism on ovarian development and gene expression characteristics need further study.</p>
</sec>
<sec>
<title>Methods</title>
<p>Here we conducted an adult-onset hypothyroidism rat model by using the methimazole (MMI) induction, then the hormone level changes and ovarian development were evaluated, furthermore, the effects of gene expression of granulosa cells and oocytes were detected by using single-cell RNA sequencing.</p>
</sec>
<sec>
<title>Results</title>
<p>Our results showed that, in addition to a decrease in thyroid hormones, the body weight was significantly reduced, while the estrus cycle was prolonged in the hypothyroidism group. Although the ovary/body weight ratio was not changed, the adult-onset hypothyroidism disrupted follicle development, primarily manifested by an increased number of atretic follicles and a decreased number of corpora lutea. Serum sex hormone levels were also imbalanced, with elevated LH, FSH, and PRL, while E2 and P were decreased. By combining single-cell RNA sequencing and the validation experiments, we found that adult-onset hypothyroidism promoted apoptosis in granulosa cells of antral follicles and induced oxidative stress in oocytes. Notably, we found significant heterogeneity in mitochondrial ROS in the control group, indicating differences in the redox status of different normal oocytes, which disappeared after hypothyroidism promoted oxidative stress.</p>
</sec>
<sec>
<title>Discussion</title>
<p>In conclusion, adult-onset hypothyroidism interferes with normal follicle development and impairs fertility by promoting apoptosis in granulosa cells of antral follicles and inducing oxidative stress in oocytes.</p>
</sec>
</abstract>
<kwd-group>
<kwd>adult-onset hypothyroidism</kwd>
<kwd>granulosa cell</kwd>
<kwd>apoptosis</kwd>
<kwd>oocyte</kwd>
<kwd>oxidative stress</kwd>
</kwd-group>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Molecular and Cellular Reproduction</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Hypothyroidism is a common endocrine disorder in women of childbearing age which could lead to the infertility (<xref ref-type="bibr" rid="B8">de Oliveira et al., 2022</xref>; <xref ref-type="bibr" rid="B23">Meng et al., 2016</xref>; <xref ref-type="bibr" rid="B19">Li and Chan, 2020</xref>; <xref ref-type="bibr" rid="B9">Feldt-Rasmussen et al., 2024</xref>). The prevalence of overt hypothyroidism in women of childbearing age ranges from 0.2% to 4.5%, while subclinical hypothyroidism is 5%&#x2013;7% (<xref ref-type="bibr" rid="B28">Poppe, 2021</xref>). Compared to men, women are more prone to developing hypothyroidism (<xref ref-type="bibr" rid="B20">Li et al., 2020</xref>). Previous studies have shown that hypothyroidism can also lead to menstrual irregularities, ovulation disorders, affect embryo implantation and development (<xref ref-type="bibr" rid="B1">Brown et al., 2023</xref>; <xref ref-type="bibr" rid="B7">Chen et al., 2023</xref>).</p>
<p>The ovary is the female reproductive organ, responsible for producing mature oocytes (<xref ref-type="bibr" rid="B11">Gershon and Dekel, 2020</xref>). The normal development of ovarian follicles is fundamental to achieving these functions. Under physiological conditions, it requires regulation by the hypothalamic-pituitary-ovarian (HPO) axis (<xref ref-type="bibr" rid="B17">Koysombat et al., 2024</xref>). The hypothalamus secretes gonadotropin-releasing hormone (GnRH), which acts on the pituitary gland. In response, the pituitary gland secretes gonadotropins that promote follicle development and the synthesis of sex hormones, such as E2 and P (<xref ref-type="bibr" rid="B6">Chen X. et al., 2022</xref>). Abnormalities of the HPO axis can lead to disorders in follicle development (<xref ref-type="bibr" rid="B27">Physiopathological determinants of human infertility, 2002</xref>; <xref ref-type="bibr" rid="B25">Mikhael et al., 2019</xref>). Meanwhile, ovarian theca cells, granulosa cells, and oocytes all express thyroid hormone receptors (THRs). Therefore thyroid hormones can directly regulate follicle development through THRs (<xref ref-type="bibr" rid="B42">Zheng et al., 2015</xref>). Previous studies have shown that hypothyroidism can reduce the number of antral follicles and increase the number of atretic follicles in rats, possibly related to oxidative stress or nitric oxide synthase system dysfunction (<xref ref-type="bibr" rid="B23">Meng et al., 2016</xref>; <xref ref-type="bibr" rid="B39">Xu et al., 2020</xref>; <xref ref-type="bibr" rid="B35">Wang et al., 2021a</xref>). However, the effects of hypothyroidism on follicle development, especially in the oocytes and granulosa cells, have not yet been well explored.</p>
<p>In the present study, we utilized a rat model to investigate how adult-onset hypothyroidism affects follicle development. We found that adult-onset hypothyroidism can lead to ovarian dysfunction in rats, affecting the synthesis of sex hormones and ovulation, which may be caused by the increase apoptosis of granulosa cells in antral follicles and induce oxidative stress in oocytes.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and methods</title>
<sec id="s2-1">
<title>Experimental design</title>
<p>The Animal Experiment Administration Committee of Tongji University approved all animal experimental procedures (TJAA06422201). Thirty-five female Sprague-Dawley (SD) rats, aged 10&#x2013;12 weeks (weighing 220&#x2013;270 g), were housed in the specific pathogen-free (SPF) facility of Tongji Hospital with free access to commercial chow. The rats were randomly assigned to control and hypothyroidism (hypo) groups. The hypo group (20 rats) received drinking water containing 0.02% (w/v) methimazole (MMI) for 4 weeks (<xref ref-type="bibr" rid="B15">Kent et al., 2022</xref>), while the control group (15 rats) received drinking water. During the modeling period, the estrus cycle of the rats was monitored daily using vaginal smears, and their body weight was measured weekly.</p>
<p>After 4 weeks, thyroid tissue and serum were collected. Hypothyroidism was mainly evaluated by serum levels of thyroid-stimulating hormone (TSH), free triiodothyronine (fT3), and free thyroxine (fT4). The serum levels of sex hormones were also measured. The bilateral ovaries were weighed and subjected to morphological evaluations. Superovulation was induced to assess ovulation capacity. Oocytes and cumulus granulosa cells were collected, and single-cell libraries were established using the Smart-seq2 method for high-throughput sequencing.</p>
</sec>
<sec id="s2-2">
<title>Enzyme-linked immunosorbent assay (ELISA)</title>
<p>Blood was collected through cardiac puncture and left at room temperature for 1 h. It was then centrifuged at 1,000 <italic>g</italic> for 20 min at 4&#xb0;C to obtain serum. According to the manufacturer&#x2019;s instructions, serum levels of thyroid hormones and sex hormones were measured using an ELISA kit (Bim, USA). Sex hormones include follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2), progesterone (P), and prolactin (PRL). Each group included at least three biological samples, each with at least three technical replicates.</p>
</sec>
<sec id="s2-3">
<title>Hematoxylin and eosin (H&#x26;E) staining</title>
<p>The thyroids and ovaries were quickly collected, with fat removed, and fixed in 4% paraformaldehyde. After dehydration with ethanol, the tissues were embedded in paraffin. Serial sections of the embedded tissue were made, each with a thickness of 5 &#x3bc;m (<xref ref-type="bibr" rid="B5">Chen M. et al., 2022</xref>). For ovarian tissue, 10 sections were randomly selected from the largest cross-section for H&#x26;E staining, and the number of follicles at different stages was counted. The criteria for determining the stages of follicles have been described previously (<xref ref-type="bibr" rid="B10">Fu et al., 2017</xref>). Ovarian follicles are classified into primordial follicles (PrF), primary follicles (PF), secondary follicles (SF), antral follicles (AF), corpora lutea (CL), and atretic follicles (AtF) (<xref ref-type="bibr" rid="B43">Zhou et al., 2023</xref>).</p>
</sec>
<sec id="s2-4">
<title>Superovulation</title>
<p>After completing the modeling, superovulation was performed in both rat groups. 40 IU of pregnant mare serum gonadotropin (PMSG) (Sansheng, China) was administered via intraperitoneal injection, followed by 40 IU of human chorionic gonadotropin (hCG) (Sansheng, China) 48 h later. After 14&#x2013;16 h, cumulus-oocyte complexes (COCs) were collected from the ampulla of the fallopian tubes (<xref ref-type="bibr" rid="B38">Wang et al., 2020</xref>). COCs were then placed in a solution of hyaluronidase (Aibei, China) for 2&#x2013;3 min to obtain denuded oocytes. The number of oocytes obtained and the proportion of abnormally morphologic oocytes were recorded.</p>
</sec>
<sec id="s2-5">
<title>Construction of cDNA library and single-cell RNA sequencing</title>
<p>Oocytes and cumulus granulosa cells were collected through superovulation, with the control group collecting 39 oocytes and their corresponding cumulus granulosa cells, and the hypo group collecting 35. The cDNA library was constructed using the Smart-seq2 method. In brief, cells were lysed to extract mRNA. The mRNA was then reverse transcribed into cDNA, followed by amplification and purification. The cDNA was fragmented, adapters were added and then amplified and purified to prepare the library. Sequencing was performed using the Illumina NovaSeq 6000 system.</p>
<p>We utilized the FPKM value as the index for measuring gene expression and analyzed gene expression in the two groups. Differentially expressed genes (DEGs) of the cumulus granulosa cells or oocytes between the hypo group and control group were identified based on &#x7c; log<sub>2</sub> (fold change) &#x7c; &#x3e;1 and <italic>P</italic> value &#x3c;0.05 using the R package. Gene ontology (GO) enrichment analysis was conducted using the R topGO package and the DAVID online tool (<ext-link ext-link-type="uri" xlink:href="https://david.ncifcrf.gov/">https://david.ncifcrf.gov/</ext-link>).</p>
</sec>
<sec id="s2-6">
<title>Quantitative real-time PCR (qPCR)</title>
<p>Ovaries were collected on the day of estrus and placed in pre-cooled M2 medium (Aibei, China). 26-gauge needles were used to puncture the antral follicles to release granulosa cells. The granulosa cells were collected from the medium by centrifugation. Following the manufacturer&#x2019;s instructions, mRNA was extracted using TRIzol (Invitrogen, USA). Reverse transcription was performed using the RevertAid First Strand cDNA Synthesis Kit (Thermo Scientific, USA), and qPCR was completed using TB Green <italic>Premix Ex Taq</italic> II (Takara, Japan). mRNA levels were normalized to <italic>&#x3b2;-actin.</italic> Each experiment was repeated at least three times independently. The primer sequences are shown in <xref ref-type="sec" rid="s12">Supplementary Table S1</xref>.</p>
</sec>
<sec id="s2-7">
<title>Terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick end labeling (TUNEL) staining</title>
<p>Ovarian paraffin sections were stained using the TUNEL staining kit (elabscience, China). In brief, sections were deparaffinized, hydrated, and permeabilized. The sections were then incubated with the Labeling Solution. DNA was subsequently stained with DAPI. After staining, the sections were observed using the fluorescence microscope (Nikon, Eclipse Ti).</p>
</sec>
<sec id="s2-8">
<title>Fluorescence staining</title>
<p>Oocytes were incubated in M2 medium containing 10 &#x3bc;M H2DCFDA (MCE, USA), 5 &#x3bc;M MitoSOX Red (MCE, USA), and 10 &#x3bc;g/mL Hoechst 33342 (Beyotime, China) at 37&#xb0;C in a 5% CO<sub>2</sub> atmosphere for 15 min. They were then washed three times in the M2 medium and observed under the fluorescence microscope.</p>
</sec>
<sec id="s2-9">
<title>Statistical analysis</title>
<p>All data were analyzed using GraphPad Prism 8 and presented as mean &#xb1; standard error of the mean (SEM). Each experiment was repeated at least three times. If the data conformed to the normal distribution, the t-test was used. If not, the Mann-Whitney test was used. <italic>P</italic> value &#x3c;0.05 was considered a significant difference. Significance was defined as &#x2a;<italic>P</italic> &#x3c; 0.05, &#x2a;&#x2a;<italic>P</italic> &#x3c; 0.01, &#x2a;&#x2a;&#x2a;<italic>P</italic> &#x3c; 0.001 and &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0001.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>Prolonged estrus cycle in rats induced by adult-onset hypothyroidism</title>
<p>To investigate the effect of adult-onset hypothyroidism on the ovarian follicle development, we first established a rat model by using methimazole (MMI). After for 4 weeks inducation, we found the thyroids were significantly enlarged in the hypothyroidism (hypo) group, while H&#x26;E staining showed that the volume of thyroids follicles were significantly smaller than that in the control group, and the colloid in the follicular cavities were reduced (<xref ref-type="fig" rid="F1">Figure 1A</xref>), while the body weight of the hypo group were significantly lower than that of the control group and showed a decreasing trend starting from the third week (<xref ref-type="fig" rid="F1">Figure 1B</xref>). The hormone assay showed the level of TSH in the hypo group was significantly higher compared with the control group, while the levels of fT3 and fT4 were remarkably lower (<xref ref-type="fig" rid="F1">Figures 1C&#x2013;E</xref>; <xref ref-type="sec" rid="s12">Supplementary Table S2</xref>), which was consistent with the hormonal changes of hypothyroidism. These results suggested that the model was successfully established (<xref ref-type="bibr" rid="B16">Korkmaz et al., 2023</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Establishment of hypothyroidism and evaluation of estrus cycle. <bold>(A)</bold> Morphological evaluation of the thyroid in the control and hypo groups. (white arrow: thyroid, black arrow: thyroid follicle). <bold>(B)</bold> Body weight changes in the control group and hypo groups during modeling (n &#x3d; 15 for control group, n &#x3d; 20 for hypo group), <sup>ns</sup>
<italic>p</italic> &#x3e; 0.05, &#x2a;&#x2a;&#x2a;<italic>P</italic> &#x3c; 0.001, &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0001. <bold>(C&#x2013;E)</bold> Serum levels of TSH, fT3, and fT4 in the control and hypo groups. Data are presented as Mean &#xb1; SEM (n &#x3d; 5 for the control group, n &#x3d; 4 for the hypo group), &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0001. <bold>(F)</bold> Representative images of the estrus cycle in the control and hypo groups.</p>
</caption>
<graphic xlink:href="fcell-13-1610694-g001.tif"/>
</fig>
<p>To determine the effect of hypothyroidism on the estrus cycle, we detected the vaginal smears for each phase including proestrus (P), estrus (E), metestrus (M), and diestrus (D) (<xref ref-type="bibr" rid="B30">Salleh et al., 2022</xref>; <xref ref-type="bibr" rid="B12">Guill&#xe9;n-Ruiz et al., 2021</xref>) (<xref ref-type="sec" rid="s12">Supplementary Figure S1A</xref>), the results showed that the estrus cycle of rats in the hypo group became irregular, primarily manifested as a significantly prolonged estrus cycle, extended from 4.37 &#xb1; 0.18 days to 6.48 &#xb1; 0.21 days, while the proportion of proestrus in the overall estrus cycle was decreased from 9.37% &#xb1; 1.88%&#x2013;5.43% &#xb1; 1.69%, and the proportion of estrus tended to increase (<xref ref-type="table" rid="T1">Table 1</xref>; <xref ref-type="sec" rid="s12">Supplementary Figures S1B,C</xref>). These data suggested that the estrus cycle was abnormal in rats with adult-onset hypothyroidism. The <xref ref-type="fig" rid="F1">Figure 1F</xref> reflects the typical estrus pattern of the two groups of rats.</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>Duration of estrus cycle and proportion of each estrus stage in control and hypo group.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th align="center">Characteristics</th>
<th align="center">Control group (n &#x3d; 15)</th>
<th align="center">Hypo group (n &#x3d; 20)</th>
<th align="center">
<italic>P</italic> value</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="center">Estrus cycle (d)</td>
<td align="center">4.37 &#xb1; 0.18</td>
<td align="center">6.48 &#xb1; 0.21</td>
<td align="center">0.0000</td>
</tr>
<tr>
<td align="center">P (%)</td>
<td align="center">9.37 &#xb1; 1.88</td>
<td align="center">5.43 &#xb1; 1.69</td>
<td align="center">0.0447</td>
</tr>
<tr>
<td align="center">E (%)</td>
<td align="center">33.33 &#xb1; 2.79</td>
<td align="center">37.53 &#xb1; 2.49</td>
<td align="center">0.2710</td>
</tr>
<tr>
<td align="center">M/D (%)</td>
<td align="center">57.30 &#xb1; 3.80</td>
<td align="center">57.04 &#xb1; 2.34</td>
<td align="center">0.5696</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn>
<p>Data are presented as Mean &#xb1; SEM (n &#x3d; 15 for the control group, n &#x3d; 20 for the hypo group).</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s3-2">
<title>Abnormal ovarian follicle development in rats with adult-onset hypothyroidism</title>
<p>To evaluate the impact of hypothyroidism on follicular development, we first collected and weighed the ovaries from both groups. Although the ovarian weight in the hypo group was significantly lower (<xref ref-type="fig" rid="F2">Figure 2A</xref>), there was no significant difference in the ovary-to-body weight ratio between the two groups (<xref ref-type="fig" rid="F2">Figure 2B</xref>). Furthermore, H&#x26;E staining showed that the number of corpora lutea (CL) in the hypo group was significantly reduced, and the number of atretic follicles (AtF) was remarkably increased, with a trend towards a decrease in antral follicles (AF) (<xref ref-type="fig" rid="F2">Figures 2C,D</xref>). Additionally, serum sex hormone levels showed significant abnormalities. Compared to the control group, levels of FSH, LH, and PRL significantly increased, while levels of E2 and P significantly decreased in the hypo group (<xref ref-type="fig" rid="F2">Figures 2E&#x2013;I</xref>; <xref ref-type="sec" rid="s12">Supplementary Table S3</xref>). These results confirmed the effects of hypothyroidism on serum sex hormone levels and follicular development.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Hypothyroidism leads to abnormal development of ovarian follicles in rats. <bold>(A)</bold> Ovary weight in the control and hypo groups after modeling. Data are presented as Mean &#xb1; SEM (n &#x3d; 5 for each group), &#x2a;<italic>p</italic> &#x3c; 0.05. <bold>(B)</bold> Ovary-to-body weight ratio in the control and hypo groups after modeling. Data are presented as Mean &#xb1; SEM (n &#x3d; 5 for each group), <sup>ns</sup>
<italic>p</italic> &#x3e; 0.05. <bold>(C,D)</bold> Representative images of H&#x26;E staining of the ovaries (right panel, grey arrow: AF, black arrow: CL, blue arrow: AtF) and statistical analysis of the number of follicles at different stages (left panel). Data are presented as Mean &#xb1; SEM (n &#x3d; 3 for each group, 5 sections per ovary are assessed), <sup>ns</sup>
<italic>p</italic> &#x3e; 0.05, &#x2a;<italic>p</italic> &#x3c; 0.05, &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0001. <bold>(E&#x2013;I)</bold> Serum levels of FSH, LH, PRL, E2, and P in rats. Data are presented as Mean &#xb1; SEM (n &#x3d; 5 for the control group, n &#x3d; 4 for the hypo group), &#x2a;&#x2a;&#x2a;<italic>P</italic> &#x3c; 0.001, &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0001. <bold>(J&#x2013;L)</bold> Representative images of oocytes (left, black arrow: oocytes with abnormal morphology) and quantitative analysis of the number (midddle) and proportion of abnormal morphology (right) in the control and hypo groups. Data are presented as Mean &#xb1; SEM (n &#x3d; 6 for each group), &#x2a;<italic>p</italic> &#x3c; 0.05, &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.001.</p>
</caption>
<graphic xlink:href="fcell-13-1610694-g002.tif"/>
</fig>
<p>Furthermore, we assessed ovulation in both groups of rats (<xref ref-type="fig" rid="F2">Figures 2J&#x2013;L</xref>). Compared to the control group, the number of oocytes retrieved from the hypo group was significantly lower, while the proportion of abnormally morphologic oocytes increased (<xref ref-type="fig" rid="F2">Figures 2K,L</xref>), indicating that hypothyroidism led to abnormal ovarian follicle development and negatively impacts ovulation.</p>
</sec>
<sec id="s3-3">
<title>Adult-onset hypothyroidism induced apoptosis in granulosa cells of antral follicles</title>
<p>Granulosa cells provide material support and facilitate signal transduction for oocytes during follicle development (<xref ref-type="bibr" rid="B4">Chen et al., 2021</xref>; <xref ref-type="bibr" rid="B18">Li et al., 2022</xref>). To further investigate how hypothyroidism impairs ovulation capacity, we focused on the potential changes in granulosa cells and oocytes. After collecting oocytes and corresponding cumulus granulosa cells from the control and hypo groups, the transcriptome was detected by using single-cell RNA sequencing. Compared to those in the control group, granulosa cells in the hypo group had a total of 1,583 differentially expressed genes (DEGs), with 941 upregulated and 642 downregulated (<xref ref-type="fig" rid="F3">Figure 3A</xref>). GO enrichment analysis showed that the upregulated DEGs were mainly enriched in apoptosis, inflammation, and oxidative stress, while the downregulated DEGs were primarily involved in gap junctions, cell proliferation, and sex hormone response (<xref ref-type="fig" rid="F3">Figure 3B</xref>), suggesting that the damage to granulosa cell function, including increased apoptosis and decreased proliferation ability, may be a critical cause of follicular atresia and oocyte maturation disorders.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Adult-onset hypothyroidism induces apoptosis in granulosa cells of antral follicles. <bold>(A)</bold> Volcano plot of differentially expressed genes (DEGs) in granulosa cells of the hypo group, with 941 upregulated and 642 downregulated genes. (n &#x3d; 5 for control group, n &#x3d; 4 for hypo group) <bold>(B)</bold> Plot illustrating the GO enrichment analysis of DEGs in granulosa cells of the hypo group. <bold>(C,D,E)</bold> Relative gene expression levels of ferroptosis (left), pyroptosis (middle), apoptosis (right) in control and hypo groups. Data are presented as Mean &#xb1; SEM (n &#x3d; 4 for each group), <sup>ns</sup>
<italic>p</italic> &#x3e; 0.05, &#x2a;<italic>p</italic> &#x3c; 0.05, &#x2a;&#x2a;<italic>p</italic> &#x3c; 0.01, &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.001. <bold>(F)</bold> TUNEL staining of follicles at different stages in both the control and hypo groups. (n &#x3d; 3 for each group, 3 sections per ovary are assessed, white arrow: TUNEL-positive) <bold>(G)</bold> Quantitative analysis of TUNEL staining in two groups. Data are presented as Mean &#xb1; SEM (n &#x3d; 3 for each group), <sup>ns</sup>
<italic>p</italic> &#x3e; 0.05, &#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.001.</p>
</caption>
<graphic xlink:href="fcell-13-1610694-g003.tif"/>
</fig>
<p>Apoptosis is one of the common ways of cell death. Single-cell RNA sequencing data suggest that adult-onset can promote granulosa cell apoptosis. In addition, previous studies have shown that ferroptosis and pyroptosis are also associated with granulosa cell death in polycystic ovarian syndrome (PCOS) and diminished ovarian reserve (DOR) (<xref ref-type="bibr" rid="B37">Wang et al., 2025</xref>; <xref ref-type="bibr" rid="B40">Yang et al., 2025</xref>), therefore, we investigated three major cell death pathways: ferroptosis, pyroptosis, and apoptosis. The ferroptosis-related genes, including Glutathione Peroxidase 4 (<italic>Gpx4</italic>), Solute Carrier Family 7 Member 11 (<italic>Slc7a11</italic>), Acyl-CoA Synthetase Long Chain Family Member 4 (<italic>Acsl4</italic>), Lysophosphatidylcholine Acyltransferase 3 (<italic>Lpcat3</italic>)<italic>,</italic> Apoptosis Inducing Factor Mitochondria Associated 2 (<italic>Aifm2</italic>), and GTP Cyclohydrolase 1 (<italic>Gch1</italic>), and the pyroptosis-related genes, including Caspase 1 (<italic>Casp1</italic>), Caspase 11 (<italic>Casp11</italic>)<italic>,</italic> Gasdermin D (<italic>Gsdmd</italic>), and Gasdermin E (<italic>Gsdme</italic>), were analyzed by qPCR. The results showed no significant differences in the expression levels of these genes between the control and hypo groups (<xref ref-type="fig" rid="F3">Figures 3C,D</xref>), indicating that the death of granulosa cells in the hypo group is not due to ferroptosis or pyroptosis.</p>
<p>We also detected the key genes involved in the apoptosis pathway, including BCL2 Apoptosis Regulator (<italic>Bcl2</italic>), BCL2 Like 1 (<italic>Bcl2l1</italic>), BCL2 Associated Agonist Of Cell Death (<italic>Bad</italic>), Caspase 3 (<italic>Casp3</italic>), and Caspase 9 (<italic>Casp9</italic>). The results indicated that the expression levels of <italic>Bcl2</italic> and <italic>Bcl2l1</italic> were significantly decreased in the hypo group, while the expression level of <italic>Bad</italic> was remarkably increased. No significant differences were observed in the expression levels of <italic>Casp3</italic> and <italic>Casp9</italic> between the groups (<xref ref-type="fig" rid="F3">Figure 3E</xref>). These results are consistent with scRNA-seq data, suggesting an enhancement of the apoptotic pathway in granulosa cells. Furthermore, we conducted TUNEL staining on paraffin sections of ovaries from both groups, focusing on the apoptosis status of granulosa cells. The results showed no significant differences in the proportion of TUNEL-positive granulosa cells between the groups in primary and secondary follicles. However, in the hypo group, especially in the pre-ovulatory stage of antral follicles (AF), the proportion of TUNEL-positive granulosa cells was significantly increased (<xref ref-type="fig" rid="F3">Figures 3F,G</xref>). These results suggested that adult-onset hypothyroidism has no effect on granulosa cells in the primary and secondary stages, but significantly induced apoptosis at the antral follicle stage, which may impact oocyte development.</p>
</sec>
<sec id="s3-4">
<title>Adult-onset hypothyroidism leads to oxidative stress in oocytes</title>
<p>To further investigate the effects of hypothyroidism and granulosa cell apoptosis on oocytes, we further analyzed single-cell transcriptome data. The analysis revealed a total of 956 DEGs in the hypo group, with 496 genes upregulated and 460 genes downregulated (<xref ref-type="fig" rid="F4">Figure 4A</xref>). GO enrichment analysis indicated that the upregulated DEGs in the hypo group were mainly enriched in pathways related to oxidative stress, cell death, and aging, while the downregulated DEGs were enriched in cell adhesion and subsequent embryo development (<xref ref-type="fig" rid="F4">Figure 4B</xref>). These findings suggest that excessive cell death and oxidative stress were common characteristics between granulosa cells and oocytes in hypothyroidism.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Adult-onset hypothyroidism leads to oxidative stress in oocytes. <bold>(A)</bold> Volcano plot of DEGs in oocytes of the hypo group, indicating 496 upregulated and 460 downregulated genes. (n &#x3d; 5 for the control group, n &#x3d; 4 for the hypo group) <bold>(B)</bold> Plot illustrating the GO enrichment analysis of DEGs in oocytes of the hypo group. <bold>(C,D)</bold> Representative images of H2DCFDA (left) and MitoSOX RED (right) staining in oocytes. (n &#x3d; 6 for each group). <bold>(E)</bold> Quantitative analysis of fluorescent staining intensity between the two groups. Data are presented as Mean &#xb1; SEM (n &#x3d; 6 for each group), &#x2a;&#x2a;&#x2a;&#x2a;<italic>p</italic> &#x3c; 0.0001.</p>
</caption>
<graphic xlink:href="fcell-13-1610694-g004.tif"/>
</fig>
<p>During the maturation of oocytes, the dynamic balance between intracellular oxidative and antioxidative systems must be maintained. Granulosa cells play a crucial role in maintaining the redox balance of oocytes, and an increase in granulosa cell apoptosis may lead to oxidative stress in oocytes (<xref ref-type="bibr" rid="B31">Shi et al., 2023</xref>). Sequencing results indicated that many upregulated DEGs in the hypo group were enriched in biological processes related to oxidative stress. Based on this, we conducted tests on relevant markers, which primarily included intracellular ROS levels (indicated by H2DCFDA staining, Green) and mitochondrial superoxide levels (indicated by MitoSOX Red staining, Red). Compared to the control group, the levels of intracellular ROS and mitochondrial superoxide were all significantly elevated in the hypo group (<xref ref-type="fig" rid="F4">Figures 4C&#x2013;E</xref>), indicating oxidative stress in oocytes of the hypo group. Notably, we found that the intracellular ROS levels of different oocytes in the control group were similar, but the levels of mitochondrial superoxide varied significantly, suggesting heterogeneity in mitochondrial superoxide levels among oocytes. However, mitochondrial superoxide levels in oocytes were increased and became similar in the hypo group (<xref ref-type="fig" rid="F4">Figures 4C,D</xref>), likely due to the apoptosis of granulosa cells.</p>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>The effect of hypothyroidism on follicle development is urgent to explore due to its high incidence rate among women of childbearing age. In this study, we investigated the impact and potential mechanisms of adult-onset hypothyroidism on ovarian function using the MMI-induced rat model. We found that adult-onset hypothyroidism interfered with the normal development of follicles, leading to an increase in the number of atretic follicles. Single-cell RNA sequencing data and experimental results indicated that adult-onset hypothyroidism increased granulosa cell apoptosis, particularly in the pre-ovulatory stage of antral follicles. Such changes disrupted the microenvironment of oocyte growth, exacerbated oxidative stress, and led to a decrease in both the quantity and quality of oocytes, ultimately resulting in impaired fertility.</p>
<p>The hypo group showed significantly increased TSH levels and decreased fT3 and fT4 levels compared to the control group. When the body is in a hypothyroid state, the serum levels of fT3 and fT4 decrease (<xref ref-type="bibr" rid="B22">McDermott, 2020</xref>). Due to the negative feedback mechanism of the hypothalamic-pituitary-thyroid axis, the pituitary gland increases the secretion of TSH (<xref ref-type="bibr" rid="B13">Hershman and Beck-Peccoz, 2023</xref>). Therefore, the results of the serum thyroid hormone measurements suggested that we successfully established an adult-onset hypothyroidism model in female rats.</p>
<p>During the modeling process, we monitored the estrus cycles of the rats daily. As modeling progressed, the estrus cycles of the hypo group became irregular, characterized by prolonged cycles and a decreased proportion of the proestrus phase. Regular estrus cycles indicate sexual maturation in rats, primarily associated with the cyclical changes in sex hormones (<xref ref-type="bibr" rid="B29">Sadowska et al., 2022</xref>). Since the cyclicity of sex hormones is linked to follicular development, these irregular estrus cycles indirectly demonstrate abnormal follicular development in hypothyroid rats.</p>
<p>Compared to the control group, the hypo group exhibited abnormal follicular development, specifically characterized by an increased number of atretic follicles, and a reduced number of corpora lutea. Follicles are crucial for sex hormone synthesis. <xref ref-type="bibr" rid="B8">de Oliveira et al. (2022)</xref> showed that hypothyroidism can lead to a decrease in LH and an increase in P. However, our results indicated that the hypo group had lower levels of E2 and P, along with higher levels of FSH, LH, and PRL. E2, one of the most important female sex hormones, is primarily synthesized and secreted by the ovaries. Combined with ovarian H&#x26;E staining results, we hypothesized that the decrease in E2 was mainly associated with the increased number of atretic follicles. The reduced number of corpora lutea likely contributes to the decrease in P levels. Follicular development is regulated by the HPO axis (<xref ref-type="bibr" rid="B32">Sirotkin et al., 2024</xref>). The decrease in E2 and P levels triggers the pituitary to secrete more FSH and LH through a negative feedback mechanism, resulting in abnormally high levels of these hormones. Additionally, excessive secretion of PRL is primarily due to elevated levels of thyrotropin-releasing hormone (TRH) (<xref ref-type="bibr" rid="B26">Molitch, 1992</xref>). Increased PRL levels interfere with the pulsatile secretion of GnRH from the hypothalamus, further disrupting the function of the HPO axis (<xref ref-type="bibr" rid="B34">Szukiewicz, 2024</xref>).</p>
<p>We assessed the ovulation capacity of the two groups of rats, focusing on both the quantity and quality of oocytes as reported (<xref ref-type="bibr" rid="B24">Miao et al., 2020</xref>). Following methods reported in previous studies (<xref ref-type="bibr" rid="B38">Wang et al., 2020</xref>), we performed superovulation in the rats. The results revealed a significant decrease in the number of oocytes obtained from the hypo group, along with an increase in the proportion of oocytes with abnormal morphology. This indicated the reduction in both the quantity and quality of oocytes in the hypo group. In rats, the number of oocytes released is positively correlated with the number of offspring, while oocyte quality determines the developmental potential of the zygote (<xref ref-type="bibr" rid="B33">Suzuki et al., 2024</xref>). These findings suggested that adult-onset hypothyroidism negatively affects ovulation capacity.</p>
<p>Granulosa cells play a crucial role in follicle development (<xref ref-type="bibr" rid="B2">Chakravarthi et al., 2021</xref>), and their excessive death is a primary cause of follicular atresia. Previous studies have shown that inflammation and oxidative stress can promote ferroptosis or pyroptosis of granulosa cells (<xref ref-type="bibr" rid="B37">Wang et al., 2025</xref>; <xref ref-type="bibr" rid="B40">Yang et al., 2025</xref>). According to our single-cell RNA sequencing results, we found that many DEGs were enriched in pathways related to inflammation, oxidative stress and apoptosis. Based on this, we further investigated the mechanisms underlying the abnormal death of granulosa cells. The qPCR results demonstrated an enhanced apoptotic pathway in granulosa cells of the hypo group. Additionally, TUNEL staining of the ovary confirmed that this pathological process predominantly occurs at the antral follicle stage. During ovulation, appropriate granulosa cell apoptosis facilitates the rupture of follicle walls and the release of oocytes (<xref ref-type="bibr" rid="B41">Zhang et al., 2024</xref>). Therefore, excessive apoptosis of granulosa cells in antral follicles may be a significant contributor to follicular atresia in hypothyroid rats.</p>
<p>Under physiological conditions, the body&#x2019;s oxidative and antioxidative systems maintain a dynamic balance. However, when oxidative substances increase abnormally or the body&#x2019;s antioxidative capacity diminishes, oxidative products can accumulate, leading to oxidative stress (<xref ref-type="bibr" rid="B36">Wang et al., 2021b</xref>; <xref ref-type="bibr" rid="B14">Hussain et al., 2021</xref>). ROS accumulation is a major cause of oxidative stress (<xref ref-type="bibr" rid="B3">Chaudhary et al., 2023</xref>), which can result in oocyte aging, characterized by decreased quantity and quality (<xref ref-type="bibr" rid="B36">Wang et al., 2021b</xref>).</p>
<p>Based on our sequencing data, we examined indicators related to oocyte oxidative stress. Fluorescent staining of oocytes revealed significantly increased levels of ROS and mitochondrial superoxide in the hypo group, indicating the presence of oxidative stress. Granulosa cells play a crucial role in supporting oocyte development by providing essential materials such as glycolytic products, cholesterol, and amino acids (<xref ref-type="bibr" rid="B21">Liu et al., 2023</xref>). The increased apoptosis of granulosa cells in the antral follicles of the hypo group may disrupt the microenvironment necessary for normal oocyte development, thus contributing to oxidative stress. However, the detailed mechanisms behind these changes warrant further exploration.</p>
<p>In conclusion, this study utilized a rat model to investigate the effects of adult-onset hypothyroidism on ovarian follicle development. The pathological process of hypothyroidism induced granulosa cell apoptosis in antral follicles, leading to oxidative stress in oocytes. This disruption in follicular development ultimately impaired the fertility of female rats. Our findings underscore that hypothyroidism in adulthood significantly affects reproductive function by compromising follicle development.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="s5">
<title>Data availability statement</title>
<p>The datasets used and analyzed during the current study are available from the corresponding author on reasonable request.</p>
</sec>
<sec sec-type="ethics-statement" id="s6">
<title>Ethics statement</title>
<p>The animal study was approved by The Animal Experiment Administration Committee of Tongji University. The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec sec-type="author-contributions" id="s7">
<title>Author contributions</title>
<p>SL: Conceptualization, Data curation, Formal Analysis, Investigation, Validation, Writing &#x2013; original draft, Writing &#x2013; review and editing. LZ: Data curation, Formal Analysis, Investigation, Writing &#x2013; review and editing. WL: Investigation, Validation, Writing &#x2013; review and editing. JQ: Investigation, Validation, Writing &#x2013; review and editing. LQ: Formal Analysis, Writing &#x2013; review and editing. XX: Investigation, Writing &#x2013; review and editing. ZX: Conceptualization, Funding acquisition, Project administration, Supervision, Writing &#x2013; review and editing. JX: Conceptualization, Formal Analysis, Project administration, Supervision, Writing &#x2013; review and editing. YJ: Conceptualization, Funding acquisition, Project administration, Supervision, Writing &#x2013; review and editing.</p>
</sec>
<sec sec-type="funding-information" id="s8">
<title>Funding</title>
<p>The author(s) declare that financial support was received for the research and/or publication of this article. This study was supported by the National Natural Science Foundation of China (82071645) and scientific research project of Tongji Hospital of Tongji University (HX1801).</p>
</sec>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="s10">
<title>Generative AI statement</title>
<p>The author(s) declare that no Generative AI was used in the creation of this manuscript.</p>
</sec>
<sec sec-type="disclaimer" id="s11">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="s12">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcell.2025.1610694/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcell.2025.1610694/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.docx" id="SM1" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname>
<given-names>E. D. L.</given-names>
</name>
<name>
<surname>Obeng-Gyasi</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>J. E.</given-names>
</name>
<name>
<surname>Shekhar</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>The thyroid hormone Axis and female reproduction</article-title>. <source>Int. J. Mol. Sci.</source> <volume>24</volume>, <fpage>9815</fpage>. <pub-id pub-id-type="doi">10.3390/ijms24129815</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chakravarthi</surname>
<given-names>V. P.</given-names>
</name>
<name>
<surname>Ratri</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Masumi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Borosha</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ghosh</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Christenson</surname>
<given-names>L. K.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Granulosa cell genes that regulate ovarian follicle development beyond the antral stage: the role of estrogen receptor &#x3b2;</article-title>. <source>Mol. Cell Endocrinol.</source> <volume>528</volume>, <fpage>111212</fpage>. <pub-id pub-id-type="doi">10.1016/j.mce.2021.111212</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chaudhary</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Chaudhary</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>T. A.</given-names>
</name>
<name>
<surname>Mishra</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Aging, oxidative stress and degenerative diseases: mechanisms, complications and emerging therapeutic strategies</article-title>. <source>Biogerontology</source> <volume>24</volume>, <fpage>609</fpage>&#x2013;<lpage>662</lpage>. <pub-id pub-id-type="doi">10.1007/s10522-023-10050-1</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Cen</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>PRMT5 regulates ovarian follicle development by facilitating Wt1 translation</article-title>. <source>Elife</source> <volume>10</volume>, <fpage>e68930</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.68930</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2022b</year>). <article-title>Resveratrol ameliorates polycystic ovary syndrome via transzonal projections within oocyte-granulosa cell communication</article-title>. <source>Theranostics</source> <volume>12</volume>, <fpage>782</fpage>&#x2013;<lpage>795</lpage>. <pub-id pub-id-type="doi">10.7150/thno.67167</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2022a</year>). <article-title>Hypothalamic mechanisms of obesity-associated disturbance of hypothalamic-pituitary-ovarian axis</article-title>. <source>Trends Endocrinol. Metab.</source> <volume>33</volume>, <fpage>206</fpage>&#x2013;<lpage>217</lpage>. <pub-id pub-id-type="doi">10.1016/j.tem.2021.12.004</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Y. T.</given-names>
</name>
<name>
<surname>Ho</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Chung</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>J. Y.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>Y. L.</given-names>
</name>
<name>
<surname>Hsiao</surname>
<given-names>T. W.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Effect of extra-low dose levothyroxine supplementation on pregnancy outcomes in women with subclinical hypothyroidism undergoing <italic>in vitro</italic> fertilization and embryo transfer</article-title>. <source>Taiwan J. Obstet. Gynecol.</source> <volume>62</volume>, <fpage>869</fpage>&#x2013;<lpage>873</lpage>. <pub-id pub-id-type="doi">10.1016/j.tjog.2023.05.014</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>de Oliveira</surname>
<given-names>L. S.</given-names>
</name>
<name>
<surname>da Silva</surname>
<given-names>T. Q. M.</given-names>
</name>
<name>
<surname>Barbosa</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Dos Anjos Cordeiro</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Santos</surname>
<given-names>L. C.</given-names>
</name>
<name>
<surname>Henriques</surname>
<given-names>P. C.</given-names>
</name>
<etal/>
</person-group> (<year>2022</year>). <article-title>Kisspeptin treatment restores ovarian function in rats with hypothyroidism</article-title>. <source>Thyroid</source> <volume>32</volume>, <fpage>1568</fpage>&#x2013;<lpage>1579</lpage>. <pub-id pub-id-type="doi">10.1089/thy.2021.0638</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feldt-Rasmussen</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Effraimidis</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bliddal</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Klose</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Consequences of undertreatment of hypothyroidism</article-title>. <source>Endocrine</source> <volume>84</volume>, <fpage>301</fpage>&#x2013;<lpage>308</lpage>. <pub-id pub-id-type="doi">10.1007/s12020-023-03460-1</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Overexpression of miR-21 in stem cells improves ovarian structure and function in rats with chemotherapy-induced ovarian damage by targeting PDCD4 and PTEN to inhibit granulosa cell apoptosis</article-title>. <source>Stem Cell Res. Ther.</source> <volume>8</volume>, <fpage>187</fpage>. <pub-id pub-id-type="doi">10.1186/s13287-017-0641-z</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gershon</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Dekel</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Newly identified regulators of ovarian folliculogenesis and ovulation</article-title>. <source>Int. J. Mol. Sci.</source> <volume>21</volume>, <fpage>4565</fpage>. <pub-id pub-id-type="doi">10.3390/ijms21124565</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guill&#xe9;n-Ruiz</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Cueto-Escobedo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hern&#xe1;ndez-L&#xf3;pez</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Rivera-Aburto</surname>
<given-names>L. E.</given-names>
</name>
<name>
<surname>Herrera-Huerta</surname>
<given-names>E. V.</given-names>
</name>
<name>
<surname>Rodr&#xed;guez-Landa</surname>
<given-names>J. F.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Estrous cycle modulates the anxiogenic effects of caffeine in the elevated plus maze and light/dark box in female rats</article-title>. <source>Behav. Brain Res.</source> <volume>413</volume>, <fpage>113469</fpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2021.113469</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hershman</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Beck-Peccoz</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Discoveries around the hypothalamic-pituitary-thyroid Axis</article-title>. <source>Thyroid</source> <volume>33</volume>, <fpage>785</fpage>&#x2013;<lpage>790</lpage>. <pub-id pub-id-type="doi">10.1089/thy.2022.0258</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hussain</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Murtaza</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Metwally</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Kalhoro</surname>
<given-names>D. H.</given-names>
</name>
<name>
<surname>Kalhoro</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Rahu</surname>
<given-names>B. A.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>The role of oxidative stress and antioxidant balance in pregnancy</article-title>. <source>Mediat. Inflamm.</source> <volume>2021</volume>, <fpage>9962860</fpage>. <pub-id pub-id-type="doi">10.1155/2021/9962860</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kent</surname>
<given-names>N. L.</given-names>
</name>
<name>
<surname>Atluri</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Cuffe</surname>
<given-names>J. S. M.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Maternal hypothyroidism in rats reduces placental lactogen, lowers insulin levels, and causes glucose intolerance</article-title>. <source>Endocrinology</source> <volume>163</volume>, <fpage>bqab231</fpage>. <pub-id pub-id-type="doi">10.1210/endocr/bqab231</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Korkmaz</surname>
<given-names>F. N.</given-names>
</name>
<name>
<surname>Yilmaz-Oral</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Asker</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Guven</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Turkcan</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kirlangic</surname>
<given-names>O. F.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Combined levothyroxine and testosterone treatment for restoring erectile dysfunction in propylthiouracil-induced hypothyroid rats</article-title>. <source>J. Sex. Med.</source> <volume>20</volume>, <fpage>732</fpage>&#x2013;<lpage>741</lpage>. <pub-id pub-id-type="doi">10.1093/jsxmed/qdad034</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koysombat</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>McGown</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Nyunt</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Abbara</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Dhillo</surname>
<given-names>W. S.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>New advances in menopause symptom management</article-title>. <source>Best. Pract. Res. Clin. Endocrinol. Metab.</source> <volume>38</volume>, <fpage>101774</fpage>. <pub-id pub-id-type="doi">10.1016/j.beem.2023.101774</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Taurine promotes estrogen synthesis by regulating microRNA-7a2 in mice ovarian granulosa cells</article-title>. <source>Biochem. Biophys. Res. Commun.</source> <volume>626</volume>, <fpage>129</fpage>&#x2013;<lpage>134</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2022.07.084</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>S. W.</given-names>
</name>
<name>
<surname>Chan</surname>
<given-names>S. Y.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Management of overt hypothyroidism during pregnancy</article-title>. <source>Best. Pract. Res. Clin. Endocrinol. Metab.</source> <volume>34</volume>, <fpage>101439</fpage>. <pub-id pub-id-type="doi">10.1016/j.beem.2020.101439</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Teng</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ba</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Efficacy and safety of long-term universal salt iodization on thyroid disorders: epidemiological evidence from 31 provinces of mainland China</article-title>. <source>Thyroid</source> <volume>30</volume>, <fpage>568</fpage>&#x2013;<lpage>579</lpage>. <pub-id pub-id-type="doi">10.1089/thy.2019.0067</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zuo</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Granulosa cell mevalonate pathway abnormalities contribute to oocyte meiotic defects and aneuploidy</article-title>. <source>Nat. Aging</source> <volume>3</volume>, <fpage>670</fpage>&#x2013;<lpage>687</lpage>. <pub-id pub-id-type="doi">10.1038/s43587-023-00419-9</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McDermott</surname>
<given-names>M. T.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Hypothyroidism</article-title>. <source>Ann. Intern Med.</source> <volume>173</volume>, <fpage>Itc1</fpage>&#x2013;<lpage>itc16</lpage>. <pub-id pub-id-type="doi">10.7326/AITC202007070</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meng</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Rijntjes</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Swarts</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Bunschoten</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>van der Stelt</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Keijer</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Dietary-induced chronic hypothyroidism negatively affects rat follicular development and ovulation rate and is associated with oxidative stress</article-title>. <source>Biol. Reprod.</source> <volume>94</volume>, <fpage>90</fpage>. <pub-id pub-id-type="doi">10.1095/biolreprod.115.136515</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Rui</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Xiong</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Nicotinamide mononucleotide supplementation reverses the declining quality of maternally aged oocytes</article-title>. <source>Cell Rep.</source> <volume>32</volume>, <fpage>107987</fpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2020.107987</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mikhael</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Punjala-Patel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gavrilova-Jordan</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Hypothalamic-pituitary-ovarian Axis disorders impacting female fertility</article-title>. <source>Biomedicines</source> <volume>7</volume>, <fpage>5</fpage>. <pub-id pub-id-type="doi">10.3390/biomedicines7010005</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Molitch</surname>
<given-names>M. E.</given-names>
</name>
</person-group> (<year>1992</year>). <article-title>Pathologic hyperprolactinemia</article-title>. <source>Endocrinol. Metab. Clin. North Am.</source> <volume>21</volume>, <fpage>877</fpage>&#x2013;<lpage>901</lpage>. <pub-id pub-id-type="doi">10.1016/s0889-8529(18)30193-2</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<collab>Physiopathological determinants of human infertility</collab> (<year>2002</year>). <article-title>Physiopathological determinants of human infertility</article-title>. <source>Hum. Reprod. Update</source> <volume>8</volume>, <fpage>435</fpage>&#x2013;<lpage>447</lpage>. <pub-id pub-id-type="doi">10.1093/humupd/8.5.435</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poppe</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Management of endocrine disease: thyroid and female infertility: more questions than answers?</article-title> <source>Eur. J. Endocrinol.</source> <volume>184</volume>, <fpage>R123</fpage>&#x2013;<lpage>R135</lpage>. <pub-id pub-id-type="doi">10.1530/EJE-20-1284</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sadowska</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Dudzi&#x144;ska</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Dziaduch</surname>
<given-names>I.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>The effect of alternating high-sucrose and sucrose free-diets, and intermittent one-day fasting on the estrous cycle and sex hormones in female rats</article-title>. <source>Nutrients</source> <volume>14</volume>, <fpage>4350</fpage>. <pub-id pub-id-type="doi">10.3390/nu14204350</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salleh</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ismail</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Nelli</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Myint</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Khaing</surname>
<given-names>S. L.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Changes in fluid composition and expression of ion channels in rat cervix during different phases of the estrus cycle</article-title>. <source>Biotech. Histochem.</source> <volume>97</volume>, <fpage>53</fpage>&#x2013;<lpage>66</lpage>. <pub-id pub-id-type="doi">10.1080/10520295.2021.1899285</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shi</surname>
<given-names>Y. Q.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>X. T.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>S. N.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>Y. F.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>Y. H.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2023</year>). <article-title>Premature ovarian insufficiency: a review on the role of oxidative stress and the application of antioxidants</article-title>. <source>Front. Endocrinol. (Lausanne)</source> <volume>14</volume>, <fpage>1172481</fpage>. <pub-id pub-id-type="doi">10.3389/fendo.2023.1172481</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sirotkin</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Fabov&#xe1;</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Loncov&#xe1;</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bauerov&#xe1;</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Halim Harrath</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>The adipokines progranulin and omentin - novel regulators of basic ovarian cell functions</article-title>. <source>Reprod. Biol. Endocrinol.</source> <volume>22</volume>, <fpage>38</fpage>. <pub-id pub-id-type="doi">10.1186/s12958-024-01215-9</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Suzuki</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Szymanska</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>Kubikova</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Perez</surname>
<given-names>C. A.</given-names>
</name>
<name>
<surname>Wells</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>The role of declining ataxia-telangiectasia-mutated (ATM) function in oocyte aging</article-title>. <source>Cell Death Discov.</source> <volume>10</volume>, <fpage>302</fpage>. <pub-id pub-id-type="doi">10.1038/s41420-024-02041-z</pub-id>
</citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szukiewicz</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2024</year>). <article-title>Current insights in prolactin signaling and ovulatory function</article-title>. <source>Int. J. Mol. Sci.</source> <volume>25</volume>, <fpage>1976</fpage>. <pub-id pub-id-type="doi">10.3390/ijms25041976</pub-id>
</citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Qi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lv</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2021a</year>). <article-title>Pathological changes and oxidative stress of the HPG axis in hypothyroid rat</article-title>. <source>J. Mol. Endocrinol.</source> <volume>67</volume>, <fpage>107</fpage>&#x2013;<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1530/JME-21-0095</pub-id>
</citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tan</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2021b</year>). <article-title>Oxidative stress in oocyte aging and female reproduction</article-title>. <source>J. Cell Physiol.</source> <volume>236</volume>, <fpage>7966</fpage>&#x2013;<lpage>7983</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.30468</pub-id>
</citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2025</year>). <article-title>SRC involves in lysosomal function and regulates ferroptosis in polycystic ovary syndrome</article-title>. <source>J. Ovarian Res.</source> <volume>18</volume>, <fpage>42</fpage>. <pub-id pub-id-type="doi">10.1186/s13048-025-01637-y</pub-id>
</citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zeng</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Quan</surname>
<given-names>R. P.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J. T.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Mutation of rat Zp2 causes ROS-mediated oocyte apoptosis</article-title>. <source>Reproduction</source> <volume>160</volume>, <fpage>353</fpage>&#x2013;<lpage>365</lpage>. <pub-id pub-id-type="doi">10.1530/REP-20-0037</pub-id>
</citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Weng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Heng</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Effect of thyroid dysfunction on NOS expression in the female rat</article-title>. <source>Cell Tissue Res.</source> <volume>379</volume>, <fpage>291</fpage>&#x2013;<lpage>300</lpage>. <pub-id pub-id-type="doi">10.1007/s00441-019-03090-y</pub-id>
</citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Mo</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Xin</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2025</year>). <article-title>Rescuing fertility: itaconic acid prevents ovarian damage through NRF2-mediated pyroptosis pathways in diminished ovarian reserve models</article-title>. <source>Cell Signal</source> <volume>131</volume>, <fpage>111766</fpage>. <pub-id pub-id-type="doi">10.1016/j.cellsig.2025.111766</pub-id>
</citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>K. H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F. F.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z. L.</given-names>
</name>
<name>
<surname>Fang</surname>
<given-names>K. F.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>W. X.</given-names>
</name>
<name>
<surname>Kong</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2024</year>). <article-title>Follicle stimulating hormone controls granulosa cell glutamine synthesis to regulate ovulation</article-title>. <source>Protein Cell</source> <volume>15</volume>, <fpage>512</fpage>&#x2013;<lpage>529</lpage>. <pub-id pub-id-type="doi">10.1093/procel/pwad065</pub-id>
</citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zheng</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Sulieman</surname>
<given-names>F. J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Nitric oxide and thyroid hormone receptor alpha 1 contribute to ovarian follicular development in immature hyper- and hypo-thyroid rats</article-title>. <source>Reprod. Biol.</source> <volume>15</volume>, <fpage>27</fpage>&#x2013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1016/j.repbio.2014.11.002</pub-id>
</citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>The transcriptome reveals the molecular regulatory network of primordial follicle depletion in obese mice</article-title>. <source>Fertil. Steril.</source> <volume>120</volume>, <fpage>899</fpage>&#x2013;<lpage>910</lpage>. <pub-id pub-id-type="doi">10.1016/j.fertnstert.2023.05.165</pub-id>
</citation>
</ref>
</ref-list>
<sec id="s13">
<title>Glossary</title>
<def-list>
<def-item>
<term id="G1-fcell.2025.1610694">
<bold>HPO</bold>
</term>
<def>
<p>hypothalamic-pituitary-ovarian</p>
</def>
</def-item>
<def-item>
<term id="G2-fcell.2025.1610694">
<bold>GnRH</bold>
</term>
<def>
<p>gonadotropin-releasing hormone</p>
</def>
</def-item>
<def-item>
<term id="G3-fcell.2025.1610694">
<bold>THRs</bold>
</term>
<def>
<p>thyroid hormone receptors</p>
</def>
</def-item>
<def-item>
<term id="G4-fcell.2025.1610694">
<bold>TSH</bold>
</term>
<def>
<p>thyroid-stimulating hormone</p>
</def>
</def-item>
<def-item>
<term id="G5-fcell.2025.1610694">
<bold>fT3</bold>
</term>
<def>
<p>free triiodothyronine</p>
</def>
</def-item>
<def-item>
<term id="G6-fcell.2025.1610694">
<bold>fT4</bold>
</term>
<def>
<p>free thyroxine</p>
</def>
</def-item>
<def-item>
<term id="G7-fcell.2025.1610694">
<bold>FSH</bold>
</term>
<def>
<p>follicle-stimulating hormone</p>
</def>
</def-item>
<def-item>
<term id="G8-fcell.2025.1610694">
<bold>LH</bold>
</term>
<def>
<p>luteinizing hormone</p>
</def>
</def-item>
<def-item>
<term id="G9-fcell.2025.1610694">
<bold>E2</bold>
</term>
<def>
<p>estradiol</p>
</def>
</def-item>
<def-item>
<term id="G10-fcell.2025.1610694">
<bold>P</bold>
</term>
<def>
<p>progesterone</p>
</def>
</def-item>
<def-item>
<term id="G11-fcell.2025.1610694">
<bold>PRL</bold>
</term>
<def>
<p>prolactin</p>
</def>
</def-item>
<def-item>
<term id="G12-fcell.2025.1610694">
<bold>PrF</bold>
</term>
<def>
<p>primordial follicles</p>
</def>
</def-item>
<def-item>
<term id="G13-fcell.2025.1610694">
<bold>PF</bold>
</term>
<def>
<p>primary follicles</p>
</def>
</def-item>
<def-item>
<term id="G14-fcell.2025.1610694">
<bold>SF</bold>
</term>
<def>
<p>secondary follicles</p>
</def>
</def-item>
<def-item>
<term id="G15-fcell.2025.1610694">
<bold>AF</bold>
</term>
<def>
<p>antral follicles</p>
</def>
</def-item>
<def-item>
<term id="G16-fcell.2025.1610694">
<bold>CL</bold>
</term>
<def>
<p>corpora lutea</p>
</def>
</def-item>
<def-item>
<term id="G17-fcell.2025.1610694">
<bold>AtF</bold>
</term>
<def>
<p>atretic follicles</p>
</def>
</def-item>
<def-item>
<term id="G18-fcell.2025.1610694">
<bold>PMSG</bold>
</term>
<def>
<p>pregnant mare serum gonadotropin</p>
</def>
</def-item>
<def-item>
<term id="G19-fcell.2025.1610694">
<bold>hCG</bold>
</term>
<def>
<p>human chorionic gonadotropin</p>
</def>
</def-item>
<def-item>
<term id="G20-fcell.2025.1610694">
<bold>COCs</bold>
</term>
<def>
<p>cumulus-oocyte complexes</p>
</def>
</def-item>
<def-item>
<term id="G21-fcell.2025.1610694">
<bold>PCOS</bold>
</term>
<def>
<p>polycystic ovarian syndrome</p>
</def>
</def-item>
<def-item>
<term id="G22-fcell.2025.1610694">
<bold>DOR</bold>
</term>
<def>
<p>diminished ovarian reserve</p>
</def>
</def-item>
<def-item>
<term id="G23-fcell.2025.1610694">
<bold>DEGs</bold>
</term>
<def>
<p>Differentially expressed genes</p>
</def>
</def-item>
<def-item>
<term id="G24-fcell.2025.1610694">
<bold>GO</bold>
</term>
<def>
<p>Gene ontology</p>
</def>
</def-item>
<def-item>
<term id="G25-fcell.2025.1610694">
<bold>MMI</bold>
</term>
<def>
<p>methimazole</p>
</def>
</def-item>
<def-item>
<term id="G26-fcell.2025.1610694">
<bold>TUNEL</bold>
</term>
<def>
<p>Terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick end labeling</p>
</def>
</def-item>
<def-item>
<term id="G27-fcell.2025.1610694">
<bold>Gpx4</bold>
</term>
<def>
<p>Glutathione Peroxidase 4</p>
</def>
</def-item>
<def-item>
<term id="G28-fcell.2025.1610694">
<bold>Slc7a11</bold>
</term>
<def>
<p>Solute Carrier Family 7 Member 11</p>
</def>
</def-item>
<def-item>
<term id="G29-fcell.2025.1610694">
<bold>Acsl4</bold>
</term>
<def>
<p>Acyl-CoA Synthetase Long Chain Family Member 4</p>
</def>
</def-item>
<def-item>
<term id="G30-fcell.2025.1610694">
<bold>Lpcat3</bold>
</term>
<def>
<p>Lysophosphatidylcholine Acyltransferase 3</p>
</def>
</def-item>
<def-item>
<term id="G31-fcell.2025.1610694">
<bold>Aifm2</bold>
</term>
<def>
<p>Apoptosis Inducing Factor Mitochondria Associated 2</p>
</def>
</def-item>
<def-item>
<term id="G32-fcell.2025.1610694">
<bold>Gch1</bold>
</term>
<def>
<p>GTP Cyclohydrolase 1</p>
</def>
</def-item>
<def-item>
<term id="G33-fcell.2025.1610694">
<bold>Casp1</bold>
</term>
<def>
<p>pyroptosis-related genes, including Caspase 1</p>
</def>
</def-item>
<def-item>
<term id="G34-fcell.2025.1610694">
<bold>Casp11</bold>
</term>
<def>
<p>Caspase 11</p>
</def>
</def-item>
<def-item>
<term id="G35-fcell.2025.1610694">
<bold>Gsdmd</bold>
</term>
<def>
<p>Gasdermin D</p>
</def>
</def-item>
<def-item>
<term id="G36-fcell.2025.1610694">
<bold>Gsdme</bold>
</term>
<def>
<p>Gasdermin E</p>
</def>
</def-item>
<def-item>
<term id="G37-fcell.2025.1610694">
<bold>Bcl2</bold>
</term>
<def>
<p>BCL2 Apoptosis Regulator</p>
</def>
</def-item>
<def-item>
<term id="G38-fcell.2025.1610694">
<bold>Bcl2l1</bold>
</term>
<def>
<p>BCL2 Like 1</p>
</def>
</def-item>
<def-item>
<term id="G39-fcell.2025.1610694">
<bold>Bad</bold>
</term>
<def>
<p>BCL2 Associated Agonist Of Cell Death</p>
</def>
</def-item>
<def-item>
<term id="G40-fcell.2025.1610694">
<bold>Casp3</bold>
</term>
<def>
<p>Caspase 3</p>
</def>
</def-item>
<def-item>
<term id="G41-fcell.2025.1610694">
<bold>Casp9</bold>
</term>
<def>
<p>Caspase 9</p>
</def>
</def-item>
</def-list>
</sec>
</back>
</article>